Stock Movers: Hanesbrands Acquisition, Palo Alto Networks Rally, Eli Lilly's Drug Launch

Hanesbrands Acquisition News

• 🤝 Hanesbrands (HBI) is trading lower, down about 7%, following news that Gildan Activewear is expected to acquire them for approximately $6 a share in cash and stock.
• 💰 The total deal values Hanesbrands at about $4.4 billion, including debt.
• ⚠️ Despite being an M&A story that typically boosts the target company, Hanesbrands is seeing a drop, with analysts waiting for more information.

Palo Alto Networks Momentum

• 🚀 Palo Alto Networks (PANW) is the biggest upside mover, rallying by about 1.8% and trading just shy of $179 a share.
• 📈 The company has received upgrades from Piper Sandler and Deutsche Bank, with Deutsche Bank raising its rating to 'buy' and setting a price target of $220 a share.
• 💡 Analysts believe investor concerns about Palo Alto Networks are overblown, especially considering the stock's strong performance and its underperformance relative to the broader cyberspace year-to-date.

Eli Lilly's Stock Performance

• 💊 Eli Lilly (LLY) is trading higher by about 1.5%, nearing $650 a share, despite two price target cuts from analysts.
• 📉 Canaccord Genuity lowered its price target from $975 to $825, and Guggenheim reduced theirs from $942 to $875.
• 🌍 The stock's rise comes as the company recently launched an injector pen for its weight-loss drug, Mounjaro, in India, signaling expansion efforts.

Coreweave's Downward Trend

• 📉 Coreweave (CRWV) continues its downward trend, down about 9% and trading at $135 a share.
• 📊 This decline follows a disappointing earnings outlook, with the company expecting third-quarter operating income between $160 million and $190 million.
• ⚠️ Margin pressures from rapid AI datacenter expansion have led to a significant increase in losses, reaching $131 million for the June quarter.